Effect of ACE Genotype on Cardiovascular Rehabilitation

Exclusion Criteria

• •relevant valvular heart disease
• •arterial hypertension (blood pressure at rest\> 140/90)
• •arrhythmogenic cardiomyopathy
• •ACE inhibitor intolerance
• •contraindication for ethical reasons
• •known or suspected non-compliance with the curriculum
• •smoker
• •drug or alcohol disease
• •inability of the patient to follow the study procedures (e.g. because of language problems, mental illness, dementia)
• •participation in another clinical trial within the last 30 days prior to confinement and during the study
• •other, clinically significant comorbidities (cardiac arrhythmia, renal insufficiency, hepatic dysfunction, connective tissue disease \[Marfan syndrome, Ehlers-Danlos syndrome\])
• •relevant valvular heart disease
• •arterial hypertension (blood pressure at rest\> 140/90)
• •arrhythmogenic cardiomyopathy
• •ACE inhibitor intolerance
• •contraindication for ethical reasons
• •known or suspected non-compliance with the curriculum
• •smoker
• •drug or alcohol disease
• •inability of the patient to follow the study procedures (e.g. because of language problems, mental illness, dementia)
• •participation in another clinical trial within the last 30 days prior to confinement and during the study
• •other, clinically significant comorbidities (cardiac arrhythmia, renal insufficiency, hepatic dysfunction, connective tissue disease \[Marfan syndrome, Ehlers-Danlos syndrome\])